๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2821434 F 01/17/2025 UNK
UNKNOWN MANUFACTURER
No batch number
Influenza Influenza
Patient recently became infected with influenza virus following seasonal influenza vaccination; This... Patient recently became infected with influenza virus following seasonal influenza vaccination; This spontaneous case, initially received on 07-Jan-2025, was reported by a health professional and concerns an Other female patient. Patient's medical history and concomitant Medications were unknown. Administration of company suspect drug: On an unknown date, the patient received Flucelvax (TIV) for Active immunization against influenza disease. Dose regimen: Not reported, Route of Administration: Not reported, Anatomical location: Not reported, Lot number: No batch number available, and will be requested upon follow-up. No additional suspect drugs. Adverse reactions/events and outcomes: On an unknown date, the Patient recently became infected with influenza virus following seasonal influenza vaccination (Medically significant, outcome: Unknown). It was reported that, the patient recently became infected with influenza virus following seasonal influenza vaccination. Flucelvax (TIV) action taken: Not Applicable Reporter's assessment: The reporter did not provide seriousness and causality assessment. The event influenza upgraded to serious considering event's clinical significance; Reporter's Comments: Due to the spontaneous nature of the case, it is considered related for reporting purposes. Causal association could not be completely ruled out in view of insufficient information, hence causality assessed as related. More
2821443 33 F CO 01/17/2025 RSV
RSV
PFIZER\WYETH
PFIZER\WYETH


Abdominal pain upper, Chills, Delivery, Exposure during pregnancy, Pre-eclampsia... Abdominal pain upper, Chills, Delivery, Exposure during pregnancy, Pre-eclampsia; Pyrexia More
Fever of 101.5 started 12 hours after receiving vaccine and lasted another 12 hours, had chills, sto... Fever of 101.5 started 12 hours after receiving vaccine and lasted another 12 hours, had chills, stomachache. I was 36 weeks pregnant (2nd pregnancy) with an estimated due date of 7/14/24. I delivered at 38 weeks due to sudden onset of preeclampsia on 7/X/24 - healthy baby at 7 lbs 4 oz. More
2821446 52 M 01/17/2025 COVID19
COVID19
UNK
UNK
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER




Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SAR... Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SARS-CoV-2 test; Culture stool, Full blood count, Influenza virus test, Malaise, Psittacosis; SARS-CoV-2 test More
malaise; psittacosis; Initial information received on 13-Jan-2025 regarding an unsolicited valid non... malaise; psittacosis; Initial information received on 13-Jan-2025 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional. This case involves a 52 years old male patient who experienced malaise and psittacosis after receiving Influenza trivalent recombinant vaccine [Flublok TIV] and Novavax covid-19 vaccine. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Citalopram (Citalopram) and Valaciclovir hydrochloride (Valtrex) for Product used for unknown indication. On 15-Nov-2024, the patient received a dose 1 of suspect influenza trivalent recombinant vaccine lot number Solution for injection not reported via intramuscular route in unknown administration site for prophylactic immunization and received a dose 1 of suspect Novavax covid-19 vaccine not produced by Sanofi Pasteur lot number not reported via intramuscular route in unknown administration site (frequency, route, strength and expiration date: not provided) for prophylactic immunization. Information regarding batch number and expiration date corresponding to the one at a time of event occurrence was requested. On 22-NOV-2024 the patient developed malaise and psittacosis (latency- 7 days). Relevant laboratory test results included: Culture stool - On an unknown date: [unknown] Full blood count - On an unknown date: [unknown] Influenza virus test - On an unknown date: [unknown] SARS-CoV-2 test - On an unknown date: [unknown] Action taken- not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Recovered / Resolved on an unknown date for both the events. More
2821447 0.5 M CO 01/17/2025 DTAPIPVHIB
SANOFI PASTEUR
UK044AA
No adverse event, Product preparation issue No adverse event, Product preparation issue
pentacel diluent was administered prior to reconstitution with no reported adverse event; Initial in... pentacel diluent was administered prior to reconstitution with no reported adverse event; Initial information received on 09-Jan-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6-month-old male patient whom diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] diluent was administered prior to reconstitution with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included rotavirus vaccine live reassort oral 5V (Rotateq); and pneumococcal vaccine conj 15V (CRM197) (Vaxneuvance) for Immunisation. On 09-Jan-2024, a 0.5 ml dose of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(VERO)/HIB(PRP/T) Vaccine Suspension for injection of lot UK044AA and expiry date: 31-Aug-2025 strength: standard frequency: once via intramuscular route in the left thigh for immunization diluent was administered prior to reconstitution with no reported adverse event (wrong technique in product usage process) (latency: on same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2821448 F SD 01/17/2025 FLU3
SANOFI PASTEUR
UT481AB
COVID-19, Dyspnoea COVID-19, Dyspnoea
covid; shortness of breath; Initial information received on 09-Jan-2025 regarding an unsolicited val... covid; shortness of breath; Initial information received on 09-Jan-2025 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional. This case involves an unknown age female patient who experienced covid and shortness of breath after receiving Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone]. The patient's past medical history, medical treatment(s), vaccination(s),concomitant medications and family history were not provided. On an unknown date, the patient received a unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine (Suspension for injection) lot UT481AB via unknown route in unknown administration site for Prophylactic vaccination (immunization) (strength, expiry date was unknown). On an unknown date the patient developed covid (covid-19) and shortness of breath (dyspnoea) (unknown latency) following the administration of Influenza Usp Trival A-B Subvirion No Preservative Vaccine. Reportedly "Caller wanted to know the ingredients of the vaccine that was injected to their sister on 2011 for them to avoid to see if there are other vaccines that could be given to the patient. " Action taken was not applicable for all the events. It was not reported if the patient received a corrective treatment for the events (shortness of breath, covid). At time of reporting, the outcome was Unknown for the events shortness of breath and covid. More
2821450 24 M TX 01/17/2025 HEP
IPV
VARCEL
DYNAVAX TECHNOLOGIES CORPORATION
SANOFI PASTEUR
MERCK & CO. INC.
945655
W1C741M
Y006523
Syncope; Syncope; Syncope Syncope; Syncope; Syncope
Patient fainted after receiving vaccines. Patient fainted after receiving vaccines.
2821451 21 F FL 01/17/2025 COVID19
IPV
MMR
VARCEL
PFIZER\BIONTECH
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.
LP1780
X1C891M
X027903
Y013347
Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function ... Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis; Asthenia, Eyelid function disorder, Facial paralysis More
Weakness, paralysis of left side of her face. Unable to close left eye. Weakness, paralysis of left side of her face. Unable to close left eye.
โœ“
2821452 1 F CO 01/17/2025 HEPA
HIBV
MNQ
PNC20
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
PFIZER\WYETH
BM4R5
Y005248
X4T99
LCC5483
Product administered to patient of inappropriate age; Product administered to pa... Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age More
Patient was accidentally given the Menvo MCV4 vaccination intended for patients over the age of 10. ... Patient was accidentally given the Menvo MCV4 vaccination intended for patients over the age of 10. Patient is a 1-year-old. We spoke with the manufacturer and have attached the information that htey sent to us this morning. After discussing with the provider, she felt that there should not be any major side effects since there are exceptions that the vaccine can be given at a younger age. Provider has reached out to mother of child x2 with no response. More
2821499 1 F NC 01/17/2025 MMRV
MERCK & CO. INC.
Y013580
Extra dose administered, Wrong product administered Extra dose administered, Wrong product administered
Nurse was attempting to give 1 year old vaccines MMR and Varicella. Nurse mistakenly grabbed ProQuad... Nurse was attempting to give 1 year old vaccines MMR and Varicella. Nurse mistakenly grabbed ProQuad and Varicella resulting in the patient receiving a double dose of Varicella. More
2821500 63 F PR 01/17/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
74nc9
Discomfort, Limb discomfort, Mobility decreased, Painful respiration, Spinal pai... Discomfort, Limb discomfort, Mobility decreased, Painful respiration, Spinal pain More
Patient, as the days went by, the effects worsened. On the first day I experienced general discomfor... Patient, as the days went by, the effects worsened. On the first day I experienced general discomfort. On the second day there was a lot of discomfort in the arm but on the third day the patient stated that she could not move, pain in the spine that prevented her mobility and when breathing she also experienced pain in the spine. she feels like she's paralyzed More
2821501 59 F NY 01/17/2025 COVID19
PFIZER\BIONTECH
LM2216
Erythema, Pruritus Erythema, Pruritus
Patient developed redness and itching Patient developed redness and itching
2821502 1 M DC 01/17/2025 FLU3
SANOFI PASTEUR

Product lot number issue Product lot number issue
PCV20 lot # was used in documentation for both the PCV20 and flu vaccine order. Unable to confirm i... PCV20 lot # was used in documentation for both the PCV20 and flu vaccine order. Unable to confirm if pt did received first flu dose. Pt advised to repeat influenza vaccination. More
2821503 17 M PA 01/17/2025 MMR
MERCK & CO. INC.
X002058
No adverse event No adverse event
NO SIGNS OR SYMPTOMS OF ADVERSE. VACCINE WAS GIVEN IM VERSES SUBCUTANOUS. DOCTOR NOTIFIED AND THIS ... NO SIGNS OR SYMPTOMS OF ADVERSE. VACCINE WAS GIVEN IM VERSES SUBCUTANOUS. DOCTOR NOTIFIED AND THIS DOSE COUNTS. NO FURTHER ACTION NEEDED More
2821504 0.08 M DC 01/17/2025 DTPPVHBHPB
PNC20
RV1
MSP VACCINE COMPANY
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
U7921AA
LC5484
5N2AN
Incorrect dose administered; Incorrect dose administered; Incorrect dose adminis... Incorrect dose administered; Incorrect dose administered; Incorrect dose administered More
Pt ordered to received 50mg dose of Beyfortus based on weight. Pt was given 100mg dose based on lot ... Pt ordered to received 50mg dose of Beyfortus based on weight. Pt was given 100mg dose based on lot number used in vaccine documentation. More
2821505 1.17 M MI 01/17/2025 HIBV
SANOFI PASTEUR

Product preparation error Product preparation error
HIB powder was mixed with a standard diluent instead of the diluent that is provided with vaccine. HIB powder was mixed with a standard diluent instead of the diluent that is provided with vaccine.
2821506 30 M DC 01/17/2025 HPV9
TDAP
MERCK & CO. INC.
SANOFI PASTEUR
Y013469
LC5482
Extra dose administered, Product lot number issue; Extra dose administered, Prod... Extra dose administered, Product lot number issue; Extra dose administered, Product lot number issue More
PCV20 lot # used for documentation of tdap vaccine. Unable to determine if pt received tdap vaccine... PCV20 lot # used for documentation of tdap vaccine. Unable to determine if pt received tdap vaccine. Additionally, pt received PCV vaccine on 12/30/24, so pt received 2 doses of PCV. More
2821507 71 M TX 01/17/2025 FLU3
SANOFI PASTEUR
u8532ca
Deafness unilateral, Sudden hearing loss Deafness unilateral, Sudden hearing loss
I received the flu vaccine on the afternoon of 01/10/2025. In the early morning hours of 01/13/2025 ... I received the flu vaccine on the afternoon of 01/10/2025. In the early morning hours of 01/13/2025 I suddenly lost hearing in my left ear. The hearing loss lasted about 16 hours. Later during the evening of 01/13/2025 my hearing gradually returned. I haven't noticed any residual effects since. More
2821508 2 F WI 01/17/2025 COVID19
MODERNA
3044186
Expired product administered Expired product administered
Patient received expired COVID vaccine. Vaccine has 60 life in fridge, given at 61 days. Patient received expired COVID vaccine. Vaccine has 60 life in fridge, given at 61 days.
2821509 66 M WV 01/17/2025 COVID19
MODERNA
3043823
Chest X-ray normal, Dyspnoea, Rash Chest X-ray normal, Dyspnoea, Rash
Rash to abdomen that resolved with Hydrocortisone cream, Mild Shortness of breath - Rash to abdomen that resolved with Hydrocortisone cream, Mild Shortness of breath -
2821510 39 M NJ 01/17/2025 COVID19
COVID19
MODERNA
MODERNA
014c21a
014c21a
Abdominal pain upper, Colitis ulcerative, Diarrhoea, Haematochezia, Immediate po... Abdominal pain upper, Colitis ulcerative, Diarrhoea, Haematochezia, Immediate post-injection reaction; Influenza like illness, Malaise More
I became very sick, flu like symptoms immediately after receiving shot. This included stomach pains ... I became very sick, flu like symptoms immediately after receiving shot. This included stomach pains and diarrhea. Stomach issues never went away and within a few days I began to see blood in my stool for the first time in my life. I've since been diagnosed with ulcerative colitis and being treated with remicaid. More
2821511 26 F MA 01/17/2025 VARCEL
MERCK & CO. INC.

Expired product administered Expired product administered
Patient was given vaccine that expired 1 day ago. Vaccine was administered on 1/10/25. Vaccine expir... Patient was given vaccine that expired 1 day ago. Vaccine was administered on 1/10/25. Vaccine expired on 1/9/25. More
2821512 56 F WI 01/17/2025 SMALLMNK
BAVARIAN NORDIC
96867
Influenza like illness, Injection site erythema, Injection site induration, Inje... Influenza like illness, Injection site erythema, Injection site induration, Injection site pruritus More
Pt was due for her 2 year booster. Pt did note on initial series (11/21/2022 & 12/20/22) signi... Pt was due for her 2 year booster. Pt did note on initial series (11/21/2022 & 12/20/22) significant vesicle development, induration and itching. VAERS was submitted (VAERS E-report 918671 submitted on 12/01/22). Patient is a Vet Pathologist who works with mpox in research lab. Pt was due for booster. Given patient Occupational Exposure risk, risk vs benefit of booster vaccination was discussed with patient including discussion if unknown if same/worsening side effects could occur again. (serum testing for immunity not available at this time) Patient decided to proceed with Jynneos booster. Booster given on 12/20/24. Pt notes side effects were significant. Photos submitted notes reddness from injection site 10 cm long with induration. Pt notes "flu like " symptoms from 12/21 to 12/23. Pt had tissue reaction fairly significant by 12/22 -12/23 (day 2 and 3). Pt notes she managed symptoms with NSAIDS and benadryl. Pt notes she took regular doses of Benadryl for 10 days to control symptoms of very intense itching at injection site . As of 1/3/25 nodular reaction was size of lima bean More
2821513 1 F MN 01/17/2025 DTPPVHBHPB
DTPPVHBHPB
DTPPVHBHPB
FLU3
FLU3
FLU3
MMR
MMR
MMR
UNK
UNK
UNK
MSP VACCINE COMPANY
MSP VACCINE COMPANY
MSP VACCINE COMPANY
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER












Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petech... Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal; Blood electrolytes normal, Contusion, Flow cytometry, Haemoglobin normal, Petechiae; Platelet count decreased, Purpura, Reticulocyte count normal, Smear test, Thrombocytopenia; White blood cell count normal More
Developed thrombocytopenia 2 weeks following vaccine administration. Has mucosal purpura, limb brui... Developed thrombocytopenia 2 weeks following vaccine administration. Has mucosal purpura, limb bruising, petechiae. More
โœ“
2821514 57 F MN 01/17/2025 PNC20
PFIZER\WYETH
LG5577
Injection site pain, Pain, Paraesthesia Injection site pain, Pain, Paraesthesia
moderate/severe pain at/around site. Patient reported tingling that radiated down her left arm for a... moderate/severe pain at/around site. Patient reported tingling that radiated down her left arm for a couple days. Pain described as sharp/burning. Since improved. More
2821515 0.58 F MD 01/17/2025 COVID19
PFIZER\BIONTECH
LN8272
No adverse event, Product preparation issue No adverse event, Product preparation issue
About 1.5hrs after administration of vaccine, vial was noted to only have enough liquid for one addi... About 1.5hrs after administration of vaccine, vial was noted to only have enough liquid for one additional COVID dose remaining (though it should have had 2 doses remaining in vial). Suspect that inadequate diluent was added to reconstitute the vaccine, resulting in administration of a more concentrated dose (unknown how concentrated) to the patient. Patient did not demonstrate any side effects. More
2821517 61 F MO 01/17/2025 VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
4H79Y
4H79Y
Chills, Erythema, Injection site reaction, Pain, Pain in extremity; Skin warm, U... Chills, Erythema, Injection site reaction, Pain, Pain in extremity; Skin warm, Urticaria More
On the following day at around 7:30 AM on Wednesday January 15th client developed a whelp the size o... On the following day at around 7:30 AM on Wednesday January 15th client developed a whelp the size of a tennis ball at injection site and then had a 3 raised areas several inches below injection site that were the size of half dollars. Her arm was very warm to touch and sore. Client also noticed left backside of shoulder had redness and warmth. Client left cheek also was reddened in appearance. She also experienced severe body chills and body aches. More
2821518 57 F PR 01/17/2025 COVID19
FLU3
VARZOS
PFIZER\BIONTECH
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
LM2219
KM5GK
94SE2
Peripheral swelling; Peripheral swelling; Peripheral swelling Peripheral swelling; Peripheral swelling; Peripheral swelling
HER RIGTH ARM WAS A LITTLE SWOLLEN, THE DAY BEFORE , ACCORDING TO THE PATIENT WAS MORE SWOLLEN AND ... HER RIGTH ARM WAS A LITTLE SWOLLEN, THE DAY BEFORE , ACCORDING TO THE PATIENT WAS MORE SWOLLEN AND HAD BEGUN TO GO DOWN More
2821519 76 F FL 01/17/2025 RSV
PFIZER\WYETH

Pain in extremity Pain in extremity
Thigh and leg pain. Pain in the front and back of thigh on the mostly the right side. Some pain on... Thigh and leg pain. Pain in the front and back of thigh on the mostly the right side. Some pain on front thigh left side. More
2821521 45 F MD 01/17/2025 COVID19
PFIZER\BIONTECH
EW0217
Idiopathic angioedema, Lip swelling, Ophthalmic migraine, Swelling, Swelling fac... Idiopathic angioedema, Lip swelling, Ophthalmic migraine, Swelling, Swelling face More
Significant swelling of lip and face, visual migraine. The swelling has occurred repeatedly afterwa... Significant swelling of lip and face, visual migraine. The swelling has occurred repeatedly afterwards. At first, the severe facial swelling happened every few months, but then increased in frequency and began occurring on other parts of the body, as well. Swelling happened multiple times per week. Was diagnosed as "idiopathic angioedema" one year ago and is controlled with daily allergy medication. Swelling returns when medication is not taken. More
2821522 3 M MN 01/17/2025 MNQ
NOVARTIS VACCINES AND DIAGNOSTICS
EK7DG
Product administered to patient of inappropriate age Product administered to patient of inappropriate age
Patient received single vial presentation rather than 2-vial presentation of Menveo. No signs or sym... Patient received single vial presentation rather than 2-vial presentation of Menveo. No signs or symptoms of adverse event. More
2821523 62 M WA 01/17/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS

Chills, Cold sweat, Injection site pain, Insomnia, Pyrexia Chills, Cold sweat, Injection site pain, Insomnia, Pyrexia
fever, cold sweats, chills difficulty sleeping lasting 36 hours. injection site soreness lasting 48... fever, cold sweats, chills difficulty sleeping lasting 36 hours. injection site soreness lasting 48 hours. More
2821524 6 M MI 01/17/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS

Inappropriate schedule of product administration Inappropriate schedule of product administration
Immunization was incorrectly given as a first dose of DTaP and first dose of IPV. Immunization was incorrectly given as a first dose of DTaP and first dose of IPV.
2821525 9 M MN 01/17/2025 MNQ
NOVARTIS VACCINES AND DIAGNOSTICS
J44K5
No adverse event, Product administered to patient of inappropriate age No adverse event, Product administered to patient of inappropriate age
Patient received single vial presentation instead of 2-vial presentation. No adverse events noted. Patient received single vial presentation instead of 2-vial presentation. No adverse events noted.
2821526 5 M MI 01/17/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS

Inappropriate schedule of product administration Inappropriate schedule of product administration
The DTaP/IPV vaccine was incorrectly given to a patient as their first dose of DTaP and first dose o... The DTaP/IPV vaccine was incorrectly given to a patient as their first dose of DTaP and first dose of IPV. More
2821527 55 F MA 01/17/2025 VARZOS
VARZOS
VARZOS
VARZOS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS


g79dh
g79dh
Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product admi... Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product administered at inappropriate site; Joint injury; Arthralgia, Immediate post-injection reaction, Pain, Periarthritis, Product administered at inappropriate site; Joint injury More
Administration was very high/superior, did not follow proper landmarks for deltoid administration, c... Administration was very high/superior, did not follow proper landmarks for deltoid administration, caused immediate extraordinary pain soon followed by impaired shoulder mobility (frozen shoulder for several days improved, but sharp pain with particular movements has persisted even now, months later), appears to have entered joint capsule rather than IM into deltoid, unknown at this time if injury/damage is permanent More
2821528 17 F MI 01/17/2025 MMRV
MERCK & CO. INC.

Product administered to patient of inappropriate age Product administered to patient of inappropriate age
MMRV was incorrectly given to this patient at the age of 17 years MMRV was incorrectly given to this patient at the age of 17 years
2821529 93 F GA 01/17/2025 RSV
GLAXOSMITHKLINE BIOLOGICALS
52z52
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient got a second dose of Arexvy after getting a dose on 12/16/23, Spoke with her on 1/17/25. She... Patient got a second dose of Arexvy after getting a dose on 12/16/23, Spoke with her on 1/17/25. She did not have any side effects that she was aware of since vaccination. More
2821530 9 F MI 01/17/2025 DTAP
GLAXOSMITHKLINE BIOLOGICALS

Product administered to patient of inappropriate age Product administered to patient of inappropriate age
The patient received a DTaP vaccine in error, as based on their age they should have received the Td... The patient received a DTaP vaccine in error, as based on their age they should have received the Tdap vaccine. More
2821531 23 F FL 01/17/2025 YF
SANOFI PASTEUR
UK118AA
Dizziness, Loss of consciousness, Presyncope Dizziness, Loss of consciousness, Presyncope
After leaving the immunization room and upon returning to the observation area the patient got light... After leaving the immunization room and upon returning to the observation area the patient got light headed and passed out exhibiting signs of a vasovagal reaction to the vaccine. The patient came to almost immediately asking what occurred. The patient had a friend with her. I spent some time with the patient. She was given water to sip on and stayed with us about 30 minutes longer. She stated she was feeling fine upon leaving. More
2821532 86 F AR 01/17/2025 COVID19
MODERNA
016B21A
COVID-19 COVID-19
hospitalization with covid infection after vaccination hospitalization with covid infection after vaccination
2821533 1 M IL 01/17/2025 COVID19
PFIZER\BIONTECH
LN6739
No adverse event No adverse event
Nos symptoms at this time Nos symptoms at this time
2821534 72 F AR 01/17/2025 COVID19
MODERNA
049L21A
COVID-19 COVID-19
hospitalization for covid infection after vaccination hospitalization for covid infection after vaccination
2821536 87 M AR 01/17/2025 COVID19
MODERNA
019H22A
COVID-19 COVID-19
hospitalization for covid infection after vaccination hospitalization for covid infection after vaccination
2821537 2 F IL 01/17/2025 COVID19
FLU3
PFIZER\BIONTECH
SANOFI PASTEUR
LN8272
UT84O8NA
No adverse event; No adverse event No adverse event; No adverse event
No symptoms at this time No symptoms at this time
2821538 13 F VA 01/17/2025 FLU3
SANOFI PASTEUR

Extra dose administered, No adverse event Extra dose administered, No adverse event
Pt received second fluzone trivalent vaccine for 24-25 season. Pt had no adverse reactions, immediat... Pt received second fluzone trivalent vaccine for 24-25 season. Pt had no adverse reactions, immediately after injection nor any adverse symptoms reported by parents in the days after administration. More
2821539 81 M AR 01/17/2025 COVID19
MODERNA
3043823
COVID-19 COVID-19
hospitalization for covid infection after vaccination hospitalization for covid infection after vaccination
2821540 53 F 01/17/2025 COVID19
PFIZER\BIONTECH

Laboratory test normal, Neurological symptom Laboratory test normal, Neurological symptom
Chronic neurologic symptoms with normal neurology evaluation and laboratory testing Chronic neurologic symptoms with normal neurology evaluation and laboratory testing
2821541 82 F FL 01/17/2025 FLU3
TDAP
VARZOS
SEQIRUS, INC.
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
388482
3bh5k
334t3
Rash; Rash; Rash Rash; Rash; Rash
Patient presents on 1/17/25, complaining of a sporadic rash on her arms. Upon RPh observation, absen... Patient presents on 1/17/25, complaining of a sporadic rash on her arms. Upon RPh observation, absence of reaction at injection site was noted, however patient does appear to have a handful of blemishes on her forearms bilaterally and one blemish underneath the left armpit. Patient was advised to address concern with her PCP, however she declined. Pharmacist then recommended to the patient to apply a mix of Benadryl and Hydrocortisone cream bid for 5 days, and if no improvement in symptoms, to seek medical care. Patient demonstrated understanding. More
2821543 59 M AR 01/17/2025 COVID19
MODERNA
068H21A
COVID-19 COVID-19
hospitalization for covid infection after vaccination hospitalization for covid infection after vaccination
2821544 85 M AR 01/17/2025 COVID19
MODERNA
3030366
COVID-19 COVID-19
hospitalization for covid infection after vaccination hospitalization for covid infection after vaccination